Discloses is a system for the wireless transmission of energy and/or signals between spatially-separated regions with no electrically-conductive connection, the conversion of energy and/or signals into other forms of energy and/or forms of signal, and the application and/or detection of same in at least one peripheral region of said system. The system allows a wireless transmission of energy between at least two spatially-separated regions without an electrically-conductive connection, energy being supplied to at least one of these regions, transmitted to at least one additional region in a wireless manner, converted on demand into other forms of energy, and applied in a peripheral region of said system. Signals can be transmitted at the same time as energy is being transmitted.

Various systems and methods are provided for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking. In general, a patient can be tracked throughout medical treatment including through initial onset of symptoms, diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment. In one embodiment, a patient and one or more medical professionals involved with treating the patient can electronically access a comprehensive treatment planning, support, and review system. The system can provide recommendations regarding diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment based on data gathered from the patient and the medical professional(s). The system can manage the tracking of multiple patients, thereby allowing for data comparison between similar aspects of medical treatments and for learning over time through continual data gathering, analysis, and assimilation to decision-making algorithms.

A system for determining the presence of cell-free non-coding RNA (cfNCR) biomarkers in interstitial fluid includes a microfluidic device for non-invasively and passively accessing interstitial fluid from a patient. The microfluidic device is formed of a substrate containing multiple vertical micro channels therethrough, wherein at a first end of each of the multiple vertical micro channels a microheater is formed for controllably ablating a portion of dry dead skin cells to access the interstitial fluid; and wherein at a second end of each of the multiple vertical micro channels is a horizontal micro channel for receiving accessed interstitial fluid from a vertical micro channel and guiding the accessed interstitial fluid to a common collection port.

A microfluidic device capable of performing nondisruptive fluid manipulations in a living host is provided. The microfluidic device may include a combinatorial multiplexer for better scaling of multiple time points and biological signal measurements. The collected samples may be transported, stored and analyzed ex vivo for analytical ease and flexibility, e.g., by a sample analysis assay chip. The microfluidics device may include structure for maintaining fluid equilibrium within the host during the sampling to avoid damage to the host or to the implant.

Various systems and methods are provided for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking. In general, a patient can be tracked throughout medical treatment including through initial onset of symptoms, diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment. In one embodiment, a patient and one or more medical professionals involved with treating the patient can electronically access a comprehensive treatment planning, support, and review system. The system can provide recommendations regarding diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment based on data gathered from the patient and the medical professional(s). The system can manage the tracking of multiple patients, thereby allowing for data comparison between similar aspects of medical treatments and for learning over time through continual data gathering, analysis, and assimilation to decision-making algorithms.

The invention relates to a system for preventing bacterial infections in needle trajectories, comprising: a percutaneous surgical instrument (1) percutaneously introducible into a tissue (3) of a patient, such as a biopsy needle, and having an outer surface made of an electrically conductive material; a contact electrode (4) applicable to the skin (3a) of a patient;

a silver coating or element (P) arranged on or forming part of the instrument (1), and configured, sized and provided so as to break down by means of electrochemical release when a current is applied thereto, releasing silver ions into its surroundings; and an electric current generator (2) arranged and configured for generating a current and inducing the temporary circulation thereof between the instrument (1) acting as an anode, the tissue (3) and the contact electrode (4) acting as a cathode, respectively, with a specific magnitude and duration for producing a massive and sudden release of silver ions for the purpose of preventing post-treatment bacterial infections.

A biopsy device includes a body, a needle, a cutter, and a tissue sample holder. The needle extends distally from the body. The cutter is longitudinally translatable relative to the needle and defines a cutter lumen. The tissue sample holder includes a rotatable member, an individual sample tray, and one or more bulk sample trays. The rotatable member defines a single chamber partially divided by a plurality of tray protrusions extending radially inwardly from a cylindrical wall of the rotatable member. The individual sample tray includes a single sample chamber that is configured to receive a single tissue sample. The bulk sample tray is configured to receive a plurality of tissue samples.

Various systems and methods are provided for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking. In general, a patient can be tracked throughout medical treatment including through initial onset of symptoms, diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment. In one embodiment, a patient and one or more medical professionals involved with treating the patient can electronically access a comprehensive treatment planning, support, and review system. The system can provide recommendations regarding diagnosis, non-surgical treatment, surgical treatment, and recovery from the surgical treatment based on data gathered from the patient and the medical professional(s). The system can manage the tracking of multiple patients, thereby allowing for data comparison between similar aspects of medical treatments and for learning over time through continual data gathering, analysis, and assimilation to decision-making algorithms.

A biopsy device includes a body, a needle, a cutter, and a tissue sample holder. The needle extends distally from the body. The cutter is longitudinally translatable relative to the needle and defines a cutter lumen. The tissue sample holder includes a rotatable member, an individual sample tray, and one or more bulk sample trays. The rotatable member defines a single chamber partially divided by a plurality of tray protrusions extending radially inwardly from a cylindrical wall of the rotatable member. The individual sample tray includes a single sample chamber that is configured to receive a single tissue sample. The bulk sample tray is configured to receive a plurality of tissue samples.

An oral fluid collection device includes a plunger and funnel to simultaneously collect and split a single specimen into metered doses for drug testing. The device may be used with collection tubes for collection of the metered doses and later testing. The device, when used, drives the metered dose into the collection tubes and removes bubbles in the specimen to provide improved accuracy in testing.